| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
2 companies
Molina Arturo Md is a Chief Medical Officer at Protagonist Therapeutics, Inc with holdings across 2 companies. Recent SEC Form 4 filings include 1 buy and 11 sells.
Estimated insider holdings value: $12.1M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 2,712 | $84.77 | $229,896.24 | -3.2% | -2.7% | - | |
| Jun 10, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 20,000 | $56.27 | $1,125,400.00 | -10.7% | -0.3% | - | |
| Mar 13, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 30,514 | $55.74 | $1,700,850.36 | -26.7% | +0.8% | +68.2% | |
| Jan 16, 2025 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 3,640 | $0.00 | - | -2.1% | +25.3% | +124.4% | |
| Nov 27, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sale+OE | 31,529 | $44.86 | $1,414,402.40 | -18.5% | -21.9% | +100.2% | |
| Nov 15, 2024 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 1,906 | $40.98 | $78,107.88 | -3.9% | -5.9% | +105.8% | |
| Nov 15, 2023 | PTGX Protagonist Therapeutics, Inc | Chief Medical Officer | Sell | 1,848 | $16.24 | $30,011.52 | -7.6% | +65.7% | +151.9% | |
| May 14, 2020 | STRO Sutro Biopharma, Inc. | Chief Medical Officer | Buy | 6,451 | $7.75 | $49,995.25 | +114.5% | - | - |